These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9691411)

  • 1. Consequences of nucleic acid amplification testing for blood transfusion centres.
    Reesink HW; Engelfriet CP; Vrielink H; Krusius T; Lankinen M; Flanagan P; Barbara J; Gill P; Dodd RY; Busch MP; Prati D; Mozzi F; Sirchia G; Diekamp U; Epstein JS; Tabor E; Martin-Vega C; Hernândez JM
    Vox Sang; 1998; 74(4):263-70. PubMed ID: 9691411
    [No Abstract]   [Full Text] [Related]  

  • 2. Standards for blood banks and transfusion services.
    QRB Qual Rev Bull; 1977 Dec; 3(12):17,22. PubMed ID: 414187
    [No Abstract]   [Full Text] [Related]  

  • 3. Standards, accreditation and proficiency testing in the management of blood and blood products in hospitals.
    Growe GH
    CMAJ; 1996 Mar; 154(6):755. PubMed ID: 8634948
    [No Abstract]   [Full Text] [Related]  

  • 4. Update: West Nile virus screening of blood donations and transfusion-associated transmission--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(13):281-4. PubMed ID: 15071426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of West Nile virus safety policies by Canadian blood services: guiding principles and a comparison between Canada and the United States.
    Vamvakas EC; Kleinman S; Hume H; Sher GD
    Transfus Med Rev; 2006 Apr; 20(2):97-109. PubMed ID: 16565024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of nucleic acid amplification techniques to increase the viral safety of blood.
    Thomas I; Mathys E; Gerard C
    Clin Lab; 2002; 48(3-4):155-60. PubMed ID: 11934217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulating transfusion therapy.
    Schmidt PJ
    Ann Clin Lab Sci; 1973; 3(4):305-6. PubMed ID: 4716709
    [No Abstract]   [Full Text] [Related]  

  • 8. The continued risk of transfusion-transmitted AIDS.
    Kolins J
    Pathologist; 1986 Jun; 40(6):9-10. PubMed ID: 10277216
    [No Abstract]   [Full Text] [Related]  

  • 9. Quality assurance of blood components prepared in the blood transfusion center/blood bank.
    Vox Sang; 1994; 67(1):99-111. PubMed ID: 7975467
    [No Abstract]   [Full Text] [Related]  

  • 10. New, faster blood test may make blood supply safer.
    AIDS Alert; 1999 Nov; 14(11):130-1. PubMed ID: 11366982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safer haemotherapy: the responsibilities of government, transfusion service, blood donors, and physician-users.
    Moore BP
    Haematologia (Budap); 1995; 27(1):39-45. PubMed ID: 12051295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of West Nile virus in blood donations--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Aug; 52(32):769-72. PubMed ID: 12917583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Guidance for industry: current good manufacturing practice for blood and blood components: (1). Quarantine and disposition of units from prior collections from donors with repeatedly reactive screening test for antibody to hepatitis C virus (anti-HCV); (2). Supplemental testing, and the notification of consignees and blood recipients of donor test results for anti-HCV;" availability--FDA. Notice.
    Fed Regist; 1998 Oct; 63(203):56198-9. PubMed ID: 10185838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The European Blood Directive--its role in blood safety.
    Seitz R
    Dev Biol (Basel); 2007; 127():147-52. PubMed ID: 17486887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. America finds hemovigilance!
    AuBuchon JP; Whitaker BI
    Transfusion; 2007 Oct; 47(10):1937-42. PubMed ID: 17880622
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk management in transfusion medicine. The AIDS era underscores the need for a unified, comprehensive risk management program for all aspects of transfusion--from donor selection to post-transfusion outcomes.
    Berte LM; Dechristopher PJ
    MLO Med Lab Obs; 1996 Mar; 28(3):28-34. PubMed ID: 10156309
    [No Abstract]   [Full Text] [Related]  

  • 17. Is haemovigilance improving transfusion practice?--The european experience.
    Strengers PF
    Dev Biol (Basel); 2007; 127():215-24. PubMed ID: 17486895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bad blood.
    Newman RJ; Podolsky D; Loeb P
    US News World Rep; 1994 Jun; 116(25):68-70, 72-8. PubMed ID: 10134824
    [No Abstract]   [Full Text] [Related]  

  • 19. [The White Book].
    Rouger P
    Transfus Clin Biol; 2008 Nov; 15(5):314-7. PubMed ID: 18922721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The advent of hepatitis C testing.
    Soloway HB
    MLO Med Lab Obs; 1990 Nov; 22(11):33-4, 36. PubMed ID: 10113528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.